✦ LIBER ✦

A phase II study of prophylactic intravesical chemotherapy with 4′-epirubicin in recurrent superficial bladder cancer: comparison of 4′-epirubicin and Adriamycin

✍ Scribed by Taro Shuin, Yoshinobu Kubota, Sumio Noguchi…

Book ID: 120777498
Publisher: Springer
Year: 1994
Tongue: English
Weight: 365 KB
Volume: 35
Category: Article
ISSN: 0344-5704
DOI: 10.1007/BF00686920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of prophylactic intrave

A phase II study of prophylactic intravesical chemotherapy with epirubicin in the treatment of superficial bladder cancer

✍ Osamu Ryoji, Hiroshi Toma, Hayakazu Nakazawa… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 459 KB

Intravesical therapy with adriamycin and

Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group

✍ A. P. M. van der Meijden; Karl-Heinz Kurth; Wim Oosterlinck; Frans M. J. Debruyn 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 387 KB

Multi-centre Phase II Study of Low Dose

Multi-centre Phase II Study of Low Dose Intravesical Epirubicin in the Treatment of Superficial Bladder Cancer

✍ P. WHELAN; J. A. CUMMING; W. H. H. GARVIE; T. B. HARGREAVE; D. KIRK; D. W. W. NE 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

The 4th study of prophylactic intravesic

The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin

✍ Yosuke Matsumura; Hideyuki Akaza; Shigeo Isaka; Susumu Kagawa; Kenkichi Koiso; T 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 397 KB

Comparison of the prophylactic usefulnes

Comparison of the prophylactic usefulness of epirubicin and doxorubicin in the treatment of superficial bladder cancer by intravesical instillation: a multicenter randomized trial

✍ Hiroshi Eto, Yasuhiko Oka, Koichi Ueno… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 498 KB

Intravesical 4′-epi-doxorubicin(epirubic

Intravesical 4′-epi-doxorubicin(epirubicin) versus bacillus calmette—guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer

✍ Michael D. Melekos; Heracles S. Chionis; George S. Paranychianakis; Houssam H. D 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

Background. The selection of the most appropriate antineoplastic agent and optimal treatment schedule for the prophylaxis of superficial bladder cancer against tumor recurrences is the subject of continual investigations. Methods. A controlled prospective trial involving 161 patients evaluated and